ロード中...

Progress and Challenges Associated with the Development of Ricin Toxin Subunit Vaccines

The past several years have seen major advances in the development of a safe and efficacious ricin toxin vaccine, including the completion of two Phase I clinical trials with two different recombinant A subunit (RTA)-based vaccines: RiVax™ and RVEc™ adsorbed to aluminum salt adjuvant, as well as a n...

詳細記述

保存先:
書誌詳細
出版年:Expert Rev Vaccines
主要な著者: Vance, David J., Mantis, Nicholas J.
フォーマット: Artigo
言語:Inglês
出版事項: 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5193006/
https://ncbi.nlm.nih.gov/pubmed/26998662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14760584.2016.1168701
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!